NCT00668330View on ClinicalTrials.gov

Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Ibandronate+alfacalcidol+calcium

Ibandronate 150 mg monthly plus daily alfacalcidol (1ug)500mg plus calcium

DRUG

placebo ibandronate+alfacalcidol+calcium

placebo ibandronate monthly plus daily alfacalcidol(1ug)500mg calcium

Trial Locations (1)

Unknown

School of Pharmacy CUHK, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00668330 - Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter